Daurinol blocks breast and lung cancer metastasis and development by inhibition of focal adhesion kinase (FAK)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Woo, Jong Kyu | - |
dc.contributor.author | Jung, Hyun Jin | - |
dc.contributor.author | Park, Ji-Youn | - |
dc.contributor.author | Kang, Ju-Hee | - |
dc.contributor.author | Il Lee, Byung | - |
dc.contributor.author | Shin, Dong Yun | - |
dc.contributor.author | Nho, Chu Won | - |
dc.contributor.author | Cho, Soo-Young | - |
dc.contributor.author | Seong, Je Kyung | - |
dc.contributor.author | Oh, Seung Hyun | - |
dc.date.available | 2020-02-27T17:43:43Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-08-22 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5830 | - |
dc.description.abstract | FAK overexpression has been reported in diverse primary and metastatic tumor tissues, supporting its pro-tumorigenic and pro-metastatic roles. Therefore, we have developed a neo-treatment strategy using daurinol to effectively treat cancer metastasis. Daurinol blocked cancer cell migration and invasion in vitro and exhibited anti-metastatic activity in an experimental metastasis model of breast and lung cancer. Daurinol selectively inhibited phosphorylation of FAK at Tyr925, Tyr576/577, and Tyr397 sites in a dose- and time-dependent manner. Daurinol effectively suppressed migration and invasion of MDA-MB-231 and A549 cancer cells. These data were associated with inhibition of expression and secretion of invasion factors, including matrix metalloproteinase (MMP) 2, MMP9, and urokinase plasminogen activator (uPA). Consistent with these in vitro results, daurinol (10 mg/kg; Oral gavage) effectively inhibited breast and lung cancer metastasis in a mouse model. In addition, daurinol showed strong suppressive activity of cell survival as revealed by colony formation assays. Analysis of cellular phenotypes revealed that inhibition of FAK phosphorylation in cancer cells limited colony formation, cell migration, and invasion, thereby reducing the cell proliferation rate. Furthermore, daurinol significantly reduced tumor development in 4-(methylnitrosoamino)-1-(3-pyridyl)-1- butanone (NNK)/benzo(a) pyrene (BaP)-treated A/J mice. Our results suggest that daurinol suppresses lung metastasis through inhibition of migration and survival via blockade of FAK activity. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.relation.isPartOf | ONCOTARGET | - |
dc.subject | EPITHELIAL-MESENCHYMAL TRANSITION | - |
dc.subject | THYROID-CANCER | - |
dc.subject | E-CADHERIN | - |
dc.subject | CELL-MIGRATION | - |
dc.subject | COLON-CANCER | - |
dc.subject | MOUSE MODEL | - |
dc.subject | EXPRESSION | - |
dc.subject | GROWTH | - |
dc.subject | ACTIVATION | - |
dc.subject | CARCINOMA | - |
dc.title | Daurinol blocks breast and lung cancer metastasis and development by inhibition of focal adhesion kinase (FAK) | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000408135600107 | - |
dc.identifier.doi | 10.18632/oncotarget.18983 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.8, no.34, pp.57058 - 57071 | - |
dc.identifier.scopusid | 2-s2.0-85029034113 | - |
dc.citation.endPage | 57071 | - |
dc.citation.startPage | 57058 | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 8 | - |
dc.citation.number | 34 | - |
dc.contributor.affiliatedAuthor | Woo, Jong Kyu | - |
dc.contributor.affiliatedAuthor | Park, Ji-Youn | - |
dc.contributor.affiliatedAuthor | Kang, Ju-Hee | - |
dc.contributor.affiliatedAuthor | Shin, Dong Yun | - |
dc.contributor.affiliatedAuthor | Oh, Seung Hyun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | daurinol | - |
dc.subject.keywordAuthor | breast cancer | - |
dc.subject.keywordAuthor | lung cancer | - |
dc.subject.keywordAuthor | FAK | - |
dc.subject.keywordAuthor | metastasis | - |
dc.subject.keywordPlus | EPITHELIAL-MESENCHYMAL TRANSITION | - |
dc.subject.keywordPlus | THYROID-CANCER | - |
dc.subject.keywordPlus | E-CADHERIN | - |
dc.subject.keywordPlus | CELL-MIGRATION | - |
dc.subject.keywordPlus | COLON-CANCER | - |
dc.subject.keywordPlus | MOUSE MODEL | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.